Imaging flow cytometry as a novel approach for the diagnosis of heparin-induced thrombocytopenia

被引:0
|
作者
Carre, Julie [1 ]
Demont, Yohann [1 ]
Mouton, Christine [2 ]
Vayne, Caroline [3 ,4 ]
Guery, Eve-Anne [3 ]
Voyer, Annelise [1 ]
Garcon, Loic [1 ,5 ]
Le Guyader, Mailys [1 ]
Demagny, Julien [1 ,5 ]
机构
[1] CHU Amiens Picardie, Serv dHematol Biol, 1 Rond Point Professeur Christian Cabrol, F-80000 Amiens, France
[2] CHU Bordeaux, Hop Haut Leveque, Lab dHematol, Bordeaux, France
[3] CHRU Tours, Serv dHematol Hemostase, Tours, France
[4] Univ Tours, INSERM Ischemia, UMR1327, Tours, France
[5] Univ Picardie Jules Verne, HEMATIM, UR666, Amiens, France
关键词
heparin-induced thrombocytopenia; imaging flow cytometry; laboratory diagnosis; PLATELETS; ASSAY;
D O I
10.1111/bjh.19945
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heparin-induced thrombocytopenia (HIT) is an adverse reaction characterized by anti-PF4-heparin antibody generation and hypercoagulability. Imaging flow cytometry (IFC) provides a detailed morphological analysis of platelets, which change upon activation. We evaluated IFC-derived morphometric features to detect platelet activation and developed a functional assay for HIT diagnosis. We analysed blood samples from 42 patients with suspected HIT and extracted platelet size, shape and texture features using IFC. The morphological features were compared with CD62P expression, light transmission aggregometry (LTA) and a serotonin release assay (SRA) in terms of their ability to predict a HIT diagnosis. Five IFC-derived morphological features (area, circularity, contrast, diameter and major axis) significantly distinguished resting from activated platelets. The major axis feature performed best for HIT diagnosis, with a sensitivity of 89.3% and a specificity of 92.9% versus functional assays (LTA/SRA); this diagnostic performance was similar to that of CD62P expression on the same platelet donors. The area and diameter had similar specificity (92.9%) and a slightly lower sensitivity (85.7%). The morphological features associated with platelet activation might be effective markers for the diagnosis of HIT, matching platelet CD62P expression assay performance. The high-throughput IFC exploration of platelet activation offers new perspectives in label-free analysis and time-saving.
引用
收藏
页码:666 / 674
页数:9
相关论文
共 50 条
  • [21] Heparin-Induced Thrombocytopenia: An Update
    Prechel, Margaret
    Walenga, Jeanine M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (05) : 483 - 496
  • [22] Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment
    Hvas, Anne-Mette
    Favaloro, Emmanuel J.
    Hellfritzsch, Maja
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (04) : 335 - 346
  • [23] Heparin-induced thrombocytopenia: laboratory diagnosis and management
    Elalamy, I
    Lecrubier, C
    Horellou, MH
    Conard, J
    Samama, MM
    ANNALS OF MEDICINE, 2000, 32 : 60 - 67
  • [24] PLATELET-AGGREGATION STUDIES FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
    ISENHART, CE
    BRANDT, JT
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (03) : 324 - 330
  • [25] Novel oral anticoagulants for heparin-induced thrombocytopenia
    Jessica W. Skelley
    Jeffrey A. Kyle
    Rachel A. Roberts
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 172 - 178
  • [26] Novel oral anticoagulants for heparin-induced thrombocytopenia
    Skelley, Jessica W.
    Kyle, Jeffrey A.
    Roberts, Rachel A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 42 (02) : 172 - 178
  • [27] Heparin-induced thrombocytopenia
    Guertler, K.
    Euchner-Wamser, I.
    Neeser, G.
    ANAESTHESIST, 2006, 55 (09): : 1009 - 1025
  • [28] Heparin-induced thrombocytopenia
    Cruz-Gonzalez, Ignacio
    Sanchez-Ledesma, Maria
    Sanchez, Pedro L.
    Jang, Ik-Kyung
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (10): : 1071 - 1082
  • [29] Heparin-induced thrombocytopenia
    Chong, BH
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) : 1471 - 1478
  • [30] Heparin-induced thrombocytopenia
    Warkentin, Theodore E.
    CURRENT OPINION IN CRITICAL CARE, 2015, 21 (06) : 576 - 585